International Derma Care LLC – Trademark Portfolio
Entity Type: 16
International Derma Care LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VITAMIN CINC, V C VITAMIN CINC, and YDC YOUR DERMA CARE. The owner is based in Orlando, FL.
6000 Metrowest Boulevard Suite 101
Orlando, FL 32835
Showing of trademarks Trademarks
Trademark Classifications
International Derma Care LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does International Derma Care LLC have?
International Derma Care LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does International Derma Care LLC file in?
International Derma Care LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 35 covers advertising; business management; business administration; office functions.
What are International Derma Care LLC's most well-known trademarks?
International Derma Care LLC's registered trademark portfolio includes well-known marks such as VITAMIN CINC, V C VITAMIN CINC, and YDC YOUR DERMA CARE. These are among 3 currently registered trademarks in the portfolio.
What is International Derma Care LLC's trademark registration success rate?
International Derma Care LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.